CME Group Inc (CME) Holdings Reduced by Huntington National Bank

Share on StockTwits

Huntington National Bank trimmed its holdings in shares of CME Group Inc (NASDAQ:CME) by 31.1% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,417 shares of the financial services provider’s stock after selling 640 shares during the period. Huntington National Bank’s holdings in CME Group were worth $234,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Sheaff Brock Investment Advisors LLC raised its holdings in CME Group by 0.3% in the 4th quarter. Sheaff Brock Investment Advisors LLC now owns 22,040 shares of the financial services provider’s stock worth $4,146,000 after purchasing an additional 60 shares during the period. Dorsey & Whitney Trust CO LLC raised its holdings in CME Group by 1.4% in the 4th quarter. Dorsey & Whitney Trust CO LLC now owns 4,575 shares of the financial services provider’s stock worth $860,000 after purchasing an additional 65 shares during the period. Private Trust Co. NA raised its holdings in CME Group by 1.9% in the 4th quarter. Private Trust Co. NA now owns 3,488 shares of the financial services provider’s stock worth $656,000 after purchasing an additional 66 shares during the period. Dubuque Bank & Trust Co. raised its holdings in CME Group by 83.1% in the 1st quarter. Dubuque Bank & Trust Co. now owns 152 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 69 shares during the period. Finally, Front Barnett Associates LLC raised its holdings in CME Group by 5.4% in the 4th quarter. Front Barnett Associates LLC now owns 1,433 shares of the financial services provider’s stock worth $267,000 after purchasing an additional 73 shares during the period. Institutional investors and hedge funds own 84.85% of the company’s stock.

In other CME Group news, CFO John W. Pietrowicz sold 2,500 shares of the business’s stock in a transaction that occurred on Wednesday, April 3rd. The stock was sold at an average price of $168.27, for a total transaction of $420,675.00. Following the completion of the transaction, the chief financial officer now owns 35,354 shares in the company, valued at $5,949,017.58. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Kathleen M. Cronin sold 8,340 shares of the business’s stock in a transaction that occurred on Thursday, March 14th. The shares were sold at an average price of $167.54, for a total value of $1,397,283.60. Following the transaction, the insider now owns 41,604 shares of the company’s stock, valued at approximately $6,970,334.16. The disclosure for this sale can be found here. In the last quarter, insiders sold 28,489 shares of company stock valued at $4,948,996. 1.20% of the stock is currently owned by company insiders.

CME has been the topic of a number of recent research reports. BidaskClub cut CME Group from a “strong-buy” rating to a “buy” rating in a report on Wednesday, January 9th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $204.00 target price on shares of CME Group in a report on Wednesday, January 9th. Bank of America reaffirmed a “neutral” rating and issued a $191.00 target price (down from $200.00) on shares of CME Group in a report on Friday, January 11th. They noted that the move was a valuation call. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $210.00 target price on shares of CME Group in a report on Friday, February 15th. Finally, JPMorgan Chase & Co. initiated coverage on CME Group in a report on Friday, February 15th. They issued an “underweight” rating and a $164.00 target price on the stock. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating and six have issued a buy rating to the stock. CME Group currently has a consensus rating of “Hold” and an average target price of $192.00.

CME opened at $172.92 on Monday. The stock has a market capitalization of $61.02 billion, a P/E ratio of 25.35, a P/E/G ratio of 3.48 and a beta of 0.29. CME Group Inc has a 12 month low of $153.90 and a 12 month high of $197.08. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 0.15.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Thursday, February 14th. The financial services provider reported $1.77 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.75 by $0.02. The company had revenue of $1.24 billion during the quarter, compared to analyst estimates of $1.22 billion. CME Group had a return on equity of 9.85% and a net margin of 45.53%. The firm’s revenue was up 37.4% on a year-over-year basis. During the same quarter last year, the business posted $1.12 earnings per share. Analysts anticipate that CME Group Inc will post 6.82 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Monday, March 25th. Investors of record on Friday, March 8th were given a $0.75 dividend. The ex-dividend date of this dividend was Thursday, March 7th. This represents a $3.00 annualized dividend and a yield of 1.73%. This is a positive change from CME Group’s previous quarterly dividend of $0.70. CME Group’s dividend payout ratio (DPR) is currently 43.99%.

TRADEMARK VIOLATION WARNING: “CME Group Inc (CME) Holdings Reduced by Huntington National Bank” was reported by Week Herald and is owned by of Week Herald. If you are viewing this article on another domain, it was illegally copied and republished in violation of international copyright legislation. The correct version of this article can be accessed at https://weekherald.com/2019/04/15/cme-group-inc-cme-holdings-reduced-by-huntington-national-bank.html.

CME Group Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Further Reading: Preferred Stock

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.